Pediatric Community-Acquired Pneumonia Treatment Guidelines

Introduction to Treatment

The American Academy of Pediatrics recommends that macrolide antibiotics should not be used as first-line monotherapy for pediatric community-acquired pneumonia in most cases, with amoxicillin being the first-line treatment for presumed bacterial pneumonia, while macrolides are reserved for atypical pathogens or added to β-lactams when the diagnosis is uncertain 1, 2, 3

For children under 5 years old, amoxicillin 90 mg/kg/day divided into 2 doses is the first-line therapy for presumed bacterial pneumonia, with the Infectious Diseases Society of America recommending this dosage 1, 2, 3
In children under 5 years old, antimicrobial therapy is often not routinely required as viral pathogens cause the majority of clinical disease, according to the Centers for Disease Control and Prevention 2, 3
For children 5 years and older, amoxicillin 90 mg/kg/day (maximum 4 g/day) remains the first-line treatment for presumed bacterial pneumonia, as recommended by the American Academy of Pediatrics 1, 2, 3, 4
A macrolide should be added to amoxicillin (not used alone) when clinical, laboratory, or radiographic features do not clearly distinguish bacterial from atypical pneumonia, as suggested by the Infectious Diseases Society of America 1, 2, 4

The guidelines prioritize amoxicillin because Streptococcus pneumoniae is the most prominent invasive bacterial pathogen causing significant morbidity and mortality in pediatric pneumonia, according to the Centers for Disease Control and Prevention 2, 3
The high dose (90 mg/kg/day) of amoxicillin is critical to overcome resistant pneumococcal strains, as recommended by the American Academy of Pediatrics 4

For hospitalized children, ampicillin or penicillin G intravenously is the first-line treatment for fully immunized children in areas with minimal penicillin resistance, as recommended by the Infectious Diseases Society of America 2, 3, 4
Ceftriaxone or cefotaxime is recommended for children not fully immunized or in regions with significant penicillin resistance, according to the American Academy of Pediatrics 1, 2, 4
A macrolide should be added to β-lactam therapy if Mycoplasma pneumoniae cannot be excluded, as suggested by the Infectious Diseases Society of America 2, 3

For children with true penicillin allergy, azithromycin becomes the first-line treatment, as recommended by the American Academy of Pediatrics 4, 5
For non-serious allergies, oral cephalosporins (cefpodoxime, cefprozil, cefuroxime) under medical supervision are preferred alternatives, according to the Infectious Diseases Society of America 5

Five days of amoxicillin is recommended for uncomplicated cases, as suggested by the American Academy of Pediatrics 4
Azithromycin course is 5 days (10 mg/kg day 1, then 5 mg/kg/day days 2-5), according to the Infectious Diseases Society of America 1